Stranger than fiction robots swim in the bloodstream

A study dealing with the idea of ​​using tiny robots that are implanted inside the body and can deliver drug doses accurately to diseased organs. Micro-bots for injecting drugs into the body

SAN FRANCISCO (USA) - A team of researchers at the Beijing Institute of Technology in China has demonstrated the potential for using hybrid nanorobots in applications to precisely deliver drug doses to human tissues and organs to speed up treatment and reduce side effects.

The study, which was reported in the scientific journal "Cyborg and Bionic Systems", which specializes in the field of robotic systems, deals with the idea of ​​using tiny robots that contain live parts that are implanted inside the body, and that can deliver drug doses accurately to diseased organs.

The website " Medical Express " specialized in medical research quoted the lead study team, Jinhua Li, a researcher at Beijing Institute of Technology, as saying that "these micro-hybrid robots are being studied extensively in the field of intelligent drug delivery based on artificial intelligence techniques in the fields of treating cancer and other diseases." ".

He stressed that micro-bots and hybrid robots that contain live and synthetic components herald a revolution in the field of medicine as they can perform surgeries according to biochemical techniques with great accuracy. In addition to cancer treatment, these robots can play an important role in cell microsurgery, fertilization, and living tissue engineering.

Microbots and Hybrid Robots Containing Living and Synthetic Components Promise to Revolutionize Medicine

In the published study, the scientific team examined the possibility of implanting robots with a size of between one and twenty micrometers inside the body, and using them to inject thrombin that causes clotting to disrupt the bloodstream that reaches cancer cells, as well as using a sperm-sized robot to deliver heparin, which causes fluidity to treat some Circulation problems in the human body.

In similar experiments, researchers in the United States devised a new technology to treat ovarian and colorectal cancer by implanting pinhead-sized drug factories inside the body to inject doses directly in order to eliminate cancer cells.

As part of the new technique, which is still in the process of experimenting with mice, “drug factories” are implanted inside the body to give continuous doses of “interleukin-2”, a natural substance that activates white blood cells to fight cancer cells.

It is reported that interleukin-2 is a type of cytokine, a class of proteins secreted within the body's immune system and used to identify and combat diseases, and this substance has received approval from the US Food and Drug Administration for use in cancer treatment.

The study team from Rice University in Houston, USA, confirms that micro-pharmaceutical factories take the shape and size of small beads that can be implanted inside the body through simple surgeries. Each pill contains cells that can produce interleukin-2 and is encased in an outer shell for protection.

And Omid Fiseh, a researcher in the field of bioengineering, was quoted as saying that the trial of the new technology on humans will start next fall because his research team is still looking at how to develop treatment programs to help cancer patients as quickly as possible, as the team chooses only medical ingredients that have been proven to be safe for people. humans, and its efficacy has been proven in numerous experiments.

He explained that "micro-pharmaceutical factories produce doses of the drug on a daily basis until the cancer cells are eliminated," adding that "once we determined the correct dose and the number of factories to be implanted inside the body, we succeeded in eliminating cancer by one hundred percent of the animals that underwent of the trial to treat ovarian cancer and seven out of eight animals with colorectal cancer.”